OTC Markets EXMKT - Delayed Quote USD
AVAX Technologies, Inc. (AVXT)
0.0001
+0.0001
+(900.00%)
At close: June 5 at 8:00:00 PM EDT
Breakdown
TTM
Total Revenue
734.5440
Gross Profit
734.5440
Operating Expense
8,250.5640
Operating Income
-7,516.0200
Net Income Common Stockholders
-7,377.9330
Diluted NI Available to Com Stockholders
-7,377.9330
Basic EPS
-0.05
Diluted EPS
-0.05
Basic Average Shares
141,637.2550
Diluted Average Shares
141,637.2550
Total Operating Income as Reported
7,516.0200
Total Expenses
8,250.5640
Net Income from Continuing & Discontinued Operation
-7,377.9330
Normalized Income
-7,377.9330
Interest Income
135.9680
EBIT
-7,516.0200
EBITDA
-7,229.3960
Reconciled Depreciation
286.6240
Net Income from Continuing Operation Net Minority Interest
-7,377.9330
Normalized EBITDA
-7,229.3960
Tax Rate for Calcs
0
Tax Effect of Unusual Items
0
9/1/57420 - 5/15/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ERGO Entia Biosciences, Inc.
0.0002
+100.00%
LVCLF Algorae Pharmaceuticals Limited
0.0054
0.00%
SQZB SQZ Biotechnologies Company
0.0390
+30.00%
NAVB Navidea Biopharmaceuticals, Inc.
0.0007
0.00%
DYAI Dyadic International, Inc.
0.9400
-0.44%
ARMP Armata Pharmaceuticals, Inc.
1.8700
-6.97%
ORGS Orgenesis Inc.
1.9500
+11.43%
COCP Cocrystal Pharma, Inc.
1.5400
0.00%
SEER Seer, Inc.
2.0700
-2.82%
PLRX Pliant Therapeutics, Inc.
1.3800
-6.12%